Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years
NCT ID: NCT02131571
Last Updated: 2018-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2014-06-30
2018-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study to Determine the Incidence of Bone Fractures in HIV-infected Patients in Spain
NCT02045537
Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients
NCT02475941
Risk Factors for Intertrochanteric Femoral Fractures With Concomitant Lateral Wall Involvement in Elderly Women
NCT07196982
HIV in Orthopaedic Skeletal Trauma Study
NCT03131947
Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program
NCT02297581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV patients older than 50 years
HIV infected patients older than 50 years in current follow up
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV infection
Exclusion Criteria
* Receiving corticosteroids or antiresorptive therapy
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose L Casado, MD
Role: PRINCIPAL_INVESTIGATOR
Ramon y Cajal Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ramon y Cajal Hospital
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC 117/13
Identifier Type: OTHER
Identifier Source: secondary_id
FractaVIH 117/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.